Takabatake T, Ise T, Ohta K, Kobayashi K
First Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.
Kidney Int Suppl. 1991 Jun;32:S122-4.
Analysis of our data in conjunction with other recent literature allows the following conclusions regarding the role of endothelin in the tubuloglomerular feedback control mechanism and in the pathogenesis of acute ischemic renal failure: (1) Endothelin reduces nephron filtration rate in the nephrons with interrupted signal perception at the macula densa, in accord with preglomerular arteriolar constriction. Yet, the increase in filtration fraction in the whole kidney clearance study suggests a preferential postglomerular arteriolar constriction. Taken together, endothelin, which is a very potent renal vasoconstrictor, seems to constrict both preglomerular and postglomerular arterioles with a predominant constriction of the latter at the doses employed. (2) The endothelin-induced natriuresis is due to a fall in tubular reabsorption, reflecting a direct tubular action, possibly related to an elevation in blood pressure. (3) At the doses of endothelin used and under the present experimental conditions, changes in the magnitude of tubuloglomerular feedback (TGF) response or the feedback characteristic could not be detected. (4) No evidence was found for a participation of endothelin in the pathogenesis of acute postischemic renal failure, as evidenced by the absence of an improvement in glomerular filtration after treatment with endothelin antiserum.
将我们的数据与其他近期文献相结合进行分析,可得出以下关于内皮素在肾小管-肾小球反馈控制机制及急性缺血性肾衰竭发病机制中作用的结论:(1) 在内皮致密斑信号感知中断的肾单位中,内皮素会降低肾单位滤过率,这与肾小球前小动脉收缩一致。然而,在全肾清除率研究中滤过分数的增加表明肾小球后小动脉存在优先收缩。综上所述,内皮素作为一种非常强效的肾血管收缩剂,在所用剂量下似乎会同时收缩肾小球前和肾小球后小动脉,且以后者的收缩为主。(2) 内皮素诱导的利钠作用是由于肾小管重吸收减少,这反映了一种直接的肾小管作用,可能与血压升高有关。(3) 在所用的内皮素剂量及当前实验条件下,未检测到肾小管-肾小球反馈(TGF)反应幅度或反馈特征的变化。(4) 未发现内皮素参与急性缺血后肾衰竭发病机制的证据,内皮素抗血清治疗后肾小球滤过未改善即证明了这一点。